Stryker has made its sixth deal announcement of the year with the completion of its acquisition of NICO Corporation in Indianapolis, Indiana. This acquisition further strengthens Stryker’s commitment to neurotechnology through tumor and stroke care. Financial terms of the deal were not disclosed.
NICO Corporation is a privately held company that provides a systematic approach to minimally invasive surgery for tumors and intracerebral hemorrhage procedures.
Stryker develops, manufactures and markets specialty surgical and medical products. These include orthopedic implants, powered surgical instruments, endoscopic systems and patient care and handling equipment. Stryker impacts more than 150 million patients annually. Stryker’s revenue for the 12 months ending December 31, 2023, was $20.5 billion.
“The acquisition of NICO Corporation expands Stryker’s portfolio of solutions for tumor resection and the treatment of intracerebral hemorrhage, the deadliest form of stroke,” said Andy Pierce, group president, MedSurg and Neurotechnology, Stryker. “As a global leader in neurosurgical access and removal tools, this strategic addition enables us to deliver differentiated, minimally invasive approaches that will drive meaningful outcomes and improve the lives of patients worldwide.”
According to data captured in the LevinPro HC database, this acquisition marks the 68th Medical Device transaction of 2024. There were 113 Medical Device deals announced during 2023, and 124 announced during 2022.
Stryker’s other healthcare M&A deals announced in 2024 include:
For our ever-growing list of hospital deals, check out our LevinPro HC database and platform.
